Cardiology
Cardiology CME
Earn Cardiology CME that fits how you practice. ReachMD offers practical, on-demand Cardiology CME/CE designed for cardiologists, fellows, APPs, and the full cardiovascular care team. Explore short, case-based activities and expert discussions across heart failure, interventional cardiology, electrophysiology, imaging, prevention, and more. Use this page to find your next activity fast. Browse learning tracks, jump into trending topics, or choose a series from our partner academies and clinical-practice resources. New activities are added regularly, so you can stay current with emerging evidence and evolving standards of care while earning credit on your schedule.
Start an activity below to earn credit or browse by topic to find the Cardiology CME most relevant to your practice.
31-45 of 212
Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
MinuteCE®Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
Anjali Tiku Owens, MD
Ahmad Masri, MD, MS
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
CME/CEBeyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
Maria Pabon, MD
Robert J. Mentz, MD, FHFSA, FACC
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
MinuteCE®From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
Ahmad Masri, MD, MS
Anjali Tiku Owens, MD
Safety in oHCM Therapy: How and When to Transition Treatment?
MinuteCE®Safety in oHCM Therapy: How and When to Transition Treatment?
Anjali Tiku Owens, MD
Cracking the Code of Obstruction: Unmet Needs in oHCM
MinuteCE®Cracking the Code of Obstruction: Unmet Needs in oHCM
Michael Nassif, MD, MSc
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
MinuteCE®From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
Michael Nassif, MD, MSc
Anjali Tiku Owens, MD
- advertisement
Ahmad Masri, MD, MS
Michael Nassif, MD, MSc
Anjali Tiku Owens, MD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CECase-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
MinuteCE®GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
Javed Butler, MD
Carolyn Lam, MD, PhD
Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
MinuteCE®Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
Prof. Dr. Johann Bauersachs
Javed Butler, MD
When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
MinuteCE®When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
Javed Butler, MD
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
MinuteCE®Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
Prof. Dr. Johann Bauersachs
Carolyn Lam, MD, PhD
- advertisement
Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
MinuteCE®Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
Prof. Dr. Johann Bauersachs
Carolyn Lam, MD, PhD
- MinuteCE®
The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite Optimized GDMT
Javed Butler, MD
Prof. Dr. Johann Bauersachs
Carolyn Lam, MD, PhD
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
CME/CEGDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
Prof. Dr. Johann Bauersachs
Carolyn Lam, MD, PhD
